Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06907693 · ClinicalTrials.gov registry record

The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI

A clinical trial of Pulmonary Arterial Hypertension, sponsored by Prisma Health-Upstate.

Active
Registry status
7
Enrollment target
1
Study location

NCT06907693: Active study of Pulmonary Arterial Hypertension, sponsored by Prisma Health-Upstate.

NCT06907693 is a study of Pulmonary Arterial Hypertension that is active but no longer recruiting, run by Prisma Health-Upstate. The registered enrollment target is 7 participants, below the 462-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06907693, a study of Pulmonary Arterial Hypertension, is active but no longer recruiting, sponsored by Prisma Health-Upstate.

ACTIVE NOT RECRUITING
Registry status
7 participants
Enrollment target
1
Study location

Study Summary

Explore the impact of drug candidate CS1 on pathological vascular remodeling of small pulmonary arteries in the disease pulmonary arterial hypertension (PAH). This sub-study for CS1-004 aims to utilize FRI, an innovative, non-invasive imaging technology to visualize how long-term use of CS1 influences structural changes in pulmonary arteries. This sub-study seeks to provide valuable insights into the potential of CS1 to transform PAH treatment in some patients enrolled in the Expanded Access Program (CS1-004).

Primary Outcome

Change from baseline to month 12 in the ratio BV5A/BV10A

Conditions Studied

Pulmonary Arterial Hypertension

Interventions

  • DIAGNOSTIC_TEST CT Pulmonary Angiography Scan

Study Locations (1)

South Carolina

  • Prisma Health - Greenville

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2025-03-14
Est. Completion 2026-03-15
Prisma Health-Upstate

67 total trials

What the registry record for NCT06907693 still lists

NCT06907693 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 462-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 1 intervention - of which CT Pulmonary Angiography Scan is the first listed.

NCT06907693 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06907693 about?

NCT06907693 is a clinical study titled "The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI". Explore the impact of drug candidate CS1 on pathological vascular remodeling of small pulmonary arteries in the disease pulmonary arterial hypertension (PAH). This sub-study for CS1-004 aims to utilize FRI, an innovative, non-invasive imaging technology to visualize how long-term use of CS1 influenc...

What is the current status of trial NCT06907693?

This trial is currently active not recruiting. The enrollment target is 7 participants. The study started on 2025-03-14. Estimated completion is 2026-03-15.

What conditions does trial NCT06907693 study?

This clinical trial studies the following conditions: Pulmonary Arterial Hypertension.

What interventions are being tested in trial NCT06907693?

The interventions under investigation include: CT Pulmonary Angiography Scan (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06907693?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06907693 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pulmonary Arterial Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06907693's enrollment target sits among peer trials

7 61st of 63 higher than 3 of 63 other Pulmonary Arterial Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pulmonary Arterial Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06907693, the US trial registry maintained by the National Library of Medicine. NCT06907693 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.